Osteonecrosis detected by whole body magnetic resonance in patients with Hodgkin Lymphoma treated by BEACOPP

Roberto Lagalla, Massimo Midiri, Ludovico La Grutta, Massimo Galia, Giuseppe Brancatelli, Domenico Albano, Caterina Patti, Antonino Mulè, Emanuele Grassedonio

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Objectives: The purpose of our retrospective review of prospectively acquired Whole Body Magnetic Resonance (WB-MRI) scans was to assess the incidence of osteonecrosis in patients who received different chemotherapies. Methods: We evaluated the WB-MRI scans performed on 42 patients with Hodgkin Lymphoma treated by three chemotherapy regimens (6ABVD, 2ABVD + 4BEACOPP, 2ABVD + 8BEACOPP), excluding patients with the main risk factors for osteonecrosis. Results: Six out of seven patients (86 %) who received eight BEACOPP and one out of five patients (20 %) treated by four BEACOPP presented osteonecrosis, with a statistically significant difference of frequency between the two groups of patients (p < 0.05); no injury has been reported in patients treated by only ABVD. Among a total of 48 osteonecrotic lesions observed, 48 % were detected in the knee; multifocal osteonecrosis were detected in six out of seven patients (86 %). Conclusions: The development of osteonecrosis is strictly related to the chemotherapy protocol adopted and the number of cycles received, with a strong correlation between the dose of corticosteroids included in the BEACOPP scheme and this complication. WB-MRI can be considered as a helpful tool that allows detecting earlier osteonecrotic lesions in patients treated with corticosteroids. Key Points: • Osteonecrosis is a possible complication of patients with Lymphoma treated by chemotherapy.• Osteonecrosis is related to the corticosteroids included within the BEACOPP protocol.• WB-MRI allows detecting osteonecrotic lesions in patients treated with corticosteroids.
Original languageEnglish
Pages (from-to)2129-2136
Number of pages8
JournalEuropean Radiology
Volume27
Publication statusPublished - 2017

Fingerprint

Osteonecrosis
Hodgkin Disease
Magnetic Resonance Spectroscopy
Adrenal Cortex Hormones
Drug Therapy
Magnetic Resonance Imaging
Lymphoma
Knee

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging

Cite this

@article{8e128cdb69ec4dbcbe1891e4ff9504a2,
title = "Osteonecrosis detected by whole body magnetic resonance in patients with Hodgkin Lymphoma treated by BEACOPP",
abstract = "Objectives: The purpose of our retrospective review of prospectively acquired Whole Body Magnetic Resonance (WB-MRI) scans was to assess the incidence of osteonecrosis in patients who received different chemotherapies. Methods: We evaluated the WB-MRI scans performed on 42 patients with Hodgkin Lymphoma treated by three chemotherapy regimens (6ABVD, 2ABVD + 4BEACOPP, 2ABVD + 8BEACOPP), excluding patients with the main risk factors for osteonecrosis. Results: Six out of seven patients (86 {\%}) who received eight BEACOPP and one out of five patients (20 {\%}) treated by four BEACOPP presented osteonecrosis, with a statistically significant difference of frequency between the two groups of patients (p < 0.05); no injury has been reported in patients treated by only ABVD. Among a total of 48 osteonecrotic lesions observed, 48 {\%} were detected in the knee; multifocal osteonecrosis were detected in six out of seven patients (86 {\%}). Conclusions: The development of osteonecrosis is strictly related to the chemotherapy protocol adopted and the number of cycles received, with a strong correlation between the dose of corticosteroids included in the BEACOPP scheme and this complication. WB-MRI can be considered as a helpful tool that allows detecting earlier osteonecrotic lesions in patients treated with corticosteroids. Key Points: • Osteonecrosis is a possible complication of patients with Lymphoma treated by chemotherapy.• Osteonecrosis is related to the corticosteroids included within the BEACOPP protocol.• WB-MRI allows detecting osteonecrotic lesions in patients treated with corticosteroids.",
author = "Roberto Lagalla and Massimo Midiri and {La Grutta}, Ludovico and Massimo Galia and Giuseppe Brancatelli and Domenico Albano and Caterina Patti and Antonino Mul{\`e} and Emanuele Grassedonio",
year = "2017",
language = "English",
volume = "27",
pages = "2129--2136",
journal = "European Radiology",
issn = "0938-7994",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Osteonecrosis detected by whole body magnetic resonance in patients with Hodgkin Lymphoma treated by BEACOPP

AU - Lagalla, Roberto

AU - Midiri, Massimo

AU - La Grutta, Ludovico

AU - Galia, Massimo

AU - Brancatelli, Giuseppe

AU - Albano, Domenico

AU - Patti, Caterina

AU - Mulè, Antonino

AU - Grassedonio, Emanuele

PY - 2017

Y1 - 2017

N2 - Objectives: The purpose of our retrospective review of prospectively acquired Whole Body Magnetic Resonance (WB-MRI) scans was to assess the incidence of osteonecrosis in patients who received different chemotherapies. Methods: We evaluated the WB-MRI scans performed on 42 patients with Hodgkin Lymphoma treated by three chemotherapy regimens (6ABVD, 2ABVD + 4BEACOPP, 2ABVD + 8BEACOPP), excluding patients with the main risk factors for osteonecrosis. Results: Six out of seven patients (86 %) who received eight BEACOPP and one out of five patients (20 %) treated by four BEACOPP presented osteonecrosis, with a statistically significant difference of frequency between the two groups of patients (p < 0.05); no injury has been reported in patients treated by only ABVD. Among a total of 48 osteonecrotic lesions observed, 48 % were detected in the knee; multifocal osteonecrosis were detected in six out of seven patients (86 %). Conclusions: The development of osteonecrosis is strictly related to the chemotherapy protocol adopted and the number of cycles received, with a strong correlation between the dose of corticosteroids included in the BEACOPP scheme and this complication. WB-MRI can be considered as a helpful tool that allows detecting earlier osteonecrotic lesions in patients treated with corticosteroids. Key Points: • Osteonecrosis is a possible complication of patients with Lymphoma treated by chemotherapy.• Osteonecrosis is related to the corticosteroids included within the BEACOPP protocol.• WB-MRI allows detecting osteonecrotic lesions in patients treated with corticosteroids.

AB - Objectives: The purpose of our retrospective review of prospectively acquired Whole Body Magnetic Resonance (WB-MRI) scans was to assess the incidence of osteonecrosis in patients who received different chemotherapies. Methods: We evaluated the WB-MRI scans performed on 42 patients with Hodgkin Lymphoma treated by three chemotherapy regimens (6ABVD, 2ABVD + 4BEACOPP, 2ABVD + 8BEACOPP), excluding patients with the main risk factors for osteonecrosis. Results: Six out of seven patients (86 %) who received eight BEACOPP and one out of five patients (20 %) treated by four BEACOPP presented osteonecrosis, with a statistically significant difference of frequency between the two groups of patients (p < 0.05); no injury has been reported in patients treated by only ABVD. Among a total of 48 osteonecrotic lesions observed, 48 % were detected in the knee; multifocal osteonecrosis were detected in six out of seven patients (86 %). Conclusions: The development of osteonecrosis is strictly related to the chemotherapy protocol adopted and the number of cycles received, with a strong correlation between the dose of corticosteroids included in the BEACOPP scheme and this complication. WB-MRI can be considered as a helpful tool that allows detecting earlier osteonecrotic lesions in patients treated with corticosteroids. Key Points: • Osteonecrosis is a possible complication of patients with Lymphoma treated by chemotherapy.• Osteonecrosis is related to the corticosteroids included within the BEACOPP protocol.• WB-MRI allows detecting osteonecrotic lesions in patients treated with corticosteroids.

UR - http://hdl.handle.net/10447/204002

UR - http://www.link.springer.de/link/service/journals/00330/index.htm

M3 - Article

VL - 27

SP - 2129

EP - 2136

JO - European Radiology

JF - European Radiology

SN - 0938-7994

ER -